Early Detection clinical trials

COGSCREEN II: Early Detection of Cognitive Impairment

This study, COGSCREEN II, aims to find better ways to spot early signs of Alzheimer's disease in people aged 60 and over. It works with local doctors to test new digital and blood tests for early detection, hoping to help people get the right treatments sooner.